This Report Provides In-Depth Analysis of the APAC Surgical Staplers Market Report Prepared by P&S Intelligence, Segmented by Product (Manual, Powered), Type (Disposable, Reusable), End User (Hospitals, Ambulatory surgical centers & clinics), Application (General Surgery, Abdominal & Pelvic surgery, Cardiac & Thoracic surgery, Orthopedic surgery), and Geographical Outlook for the Period of 2019 to 2032
Explore the market potential with our data-driven report
APAC Surgical Staplers Market Analysis
The Asia-Pacific (APAC) surgical staples market size was USD 479.2 million in 2024, and it will grow by 7.9% during 2025–2032, to reach USD 870.6 million by 2032.
The market growth is driven by the increasing popularity of minimally invasive surgeries, rapid technological advancements, shifting inclination toward staplers from sutures, and increasing number of people with chronic illnesses. The rising demand for cosmetic surgeries and the growing wellness tourism industry in developing economies, such as India, also propels the market growth.
Advanced staples are now widely used in surgeries for tissue approximation and excision and are used to minimize the localized inflammation, incision size, and healing duration.
In India, the Central Drugs Standard Control Organisation has regulated significant changes for healthcare devices and implemented measures mandating manufacturers and importers to obtain licenses. Additionally, Class C and D medical devices must be licensed, with India expanding its accredited Medical Device Testing Laboratories for better quality assurance.
Smart Surgical Staplers with Feeding Sensing and Feedback Technologies Are Key Trend
The growing demand for advanced staplers integrated with feedback and detection technologies is a key trend in the market.
They are used by surgeons to make live adjustments by measuring tissue depth, compressive force, and staple-line construction.
This minimizes the risk of complications, including hemorrhaging and leakage, in serious surgeries, such as those of the thorax.
Smart staples contribute to accuracy and safety, prevent post-surgical complications, and improve clinical outcomes, especially in the elderly.
Governments in Japan and South Korea are implementing various policies and health reforms for adopting AI- and sensor-based devices.
The ASEAN Medical Device Directive aims at simplified regulatory approvals across Southeast Asia, facilitating simple approval throughout the region for timely efficiency and faster access.
The NMPA of China has implemented the Expedited Approval Access program under the Special Review Procedure for Innovative Medical Devices in China.
In 2023, 69 innovations were approved by the NMPA from 466 applications, including advanced surgical equipment, such as powered and sensor-based staplers.
The NMPA’s 2023 revision of 247 medical device protocols promotes local testing and innovations.
Universal Healthcare and Government-Funded Insurance Schemes Drives Market
The broadening of universal healthcare access and widespread social insurance schemes is a key driver.
It increases access to surgical care, especially for low- and middle-income populations, and improves surgical procedures in private and public hospitals.
As more consumers are eligible for subsidized surgeries, the demand for efficient, safe, and affordable tools, such as staplers, is increasing.
More than 95% of the Chinese population is covered by public health insurance under the Healthy China 2030 plan and basic medical insurance schemes, which aim to provide full access to surgical treatments.
Indonesia’s national health insurance program, Jaminan Kesehatan Nasional, covers more than 250 million people, which has increased the surgery volume in public hospitals.
Thailand’s Universal Coverage Scheme, also known as the 30-baht scheme, offers complete care to all residents with a full budget.
In September 2024, India’s Ayushman Bharat PM-JAY scheme expanded to surgical care by taking over 30,529 hospitals, which include 17,063 public and 13,466 private hospitals, assuring a wide network of healthcare facilities.
Additionally, in Karnataka, the state-level program drove a major rise in the number of cancer-related surgeries between 2018–2019 and 2024–2025, highlighting a strong increase in the demand for surgical staplers.
The manual category held the larger market share, of 70%, in 2024, because they are cost-effective and uncomplicated. Moreover, being independent of batteries and electricity makes them widely accessible for hospitals with limited power access, especially in emerging economies, such as Indonesia and Vietnam. They are strongly preferred by surgeons preferring traditional techniques. Moreover, basic surgical procedures, such as cesarean sections, drives the demand for manual devices. According to a survey, in India, the volume of C-sections increased from 17.2% in 2019 to 21.5% in 2021.
The powered category will have the higher CAGR, of approx. 8%, due to the rising demand for pinhole surgeries, which require high precision and reliable staple placement. These staplers are used to minimize surgeon fatigue and improve surgical performance, especially in complex procedures, such as organ transplants.
The products analyzed in this report are:
Manual (Larger Category)
Powered (Faster-Growing Category)
Type Analysis
The disposable category held the larger market share, of 75%, in 2024, because they are pre-disinfected and designed for one-time use, which minimizes the risk of wound infection. Hospitals and surgery centers in China, India, and Japan prefer these devices to secure hygiene and observance standards, especially in emergency procedures. These devices are accessible in rural or under-resourced healthcare facilities, where sterilization systems, such as autoclaves are limited. These devices are also quick more practical.
The reusable category will have the higher CAGR, because they provide long-term advantages in a high-capacity healthcare environment. They are also gaining popularity due to the rising adoption of eco-friendly practices. The quick advancements in hospital sterilization infrastructure and infection control practices have made reusable surgical staplers safer. Moreover, the rising ecological concerns and strengthening focus on waste management drive healthcare facilities to use reusable solutions.
The types analyzed in this report are:
Disposable (Larger Category)
Reusable (Faster-Growing Category)
End User Analysis
The hospitals category held the larger market share, of 70%, in 2024, due to the increasing volume and complexity of operations performed in hospitals, including orthopedic, cardiovascular, and emergency surgeries, which extensively require stapling devices. As per 2022 reports, in China, CVDs caused more than 40% of the total deaths. They have well-managed budgets, extensive device inventories, such as disposable, reusable, and powered; and integration with most public and private reimbursement systems in their respective countries.
The ambulatory surgical centers & clinics category will have the higher CAGR, because of the push for same-day surgeries, which minimize expenditure, offer faster recovery, and enhance patient comfort. These centers invest in stapler devices to promote high-performance and minimally invasive procedures.
The abdominal & pelvic surgery category held the largest market share, of 40% in 2024, because they are widely performed in private and public hospitals. These surgeries include colorectal resections, bariatric surgeries, hysterectomies, and appendectomies, which require precise tissue handling and firm closure. Moreover, the rise in the incidence of gastrointestinal and gynecological conditions and the increase in the volume of obesity-related surgeries in highly populated countries, primarily China and India, lead to the rising volume of abdominal and pelvic surgeries.
The orthopedic surgery category will have the highest CAGR, of approx. 8.5%, due to the growing prevalence of musculoskeletal conditions, rising incidence of physical injuries, and ballooning aging population in Japan, South Korea, and Australia. These alterations are driving the demand for spinal surgeries, fracture repairs, and joint replacements. As per 2023 reports, around 36.2 million elderly individuals aged 65 and above lived in Japan, while nearly 18.4% of South Korea's and 17.38% of Australia's population fell in this age group.
The applications analyzed in this report are:
General Surgery
Abdominal & Pelvic surgery (Largest Category)
Cardiac & Thoracic surgery
Orthopedic surgery (Fastest-Growing Category)
Drive strategic growth with comprehensive market analysis
China held the largest market share, of 40%, in 2024, due to its extensive surgical volume, robust domestic manufacturing sector, and supportive regulatory measures. China faces rising demand for surgeries due to an aging population and high prevalence of chronic diseases. According to the National Health Commission, over 264 million people in China were aged 60 or older in 2023, accounting for nearly 19% of the population. Cardiovascular diseases affect over 330 million people, with stroke and ischemic heart disease leading surgical interventions (China CDC, 2022). Osteoarthritis, impacting 50 million individuals, and cancers—such as lung and colorectal—also drive surgical needs. The prevalence of diabetes is around 12.8%, affecting over 140 million adults (JAMA, 2020). These conditions significantly increase surgical demand, especially among the elderly.
The Healthy China 2030 policy and continuous healthcare improvements under China’s 14th Five-Year Plan boost investments in the advancement of the healthcare infrastructure through local ingenuity. Moreover, the rising focus on the local production of Class III medical devices under Made in China’s 2025 initiative has given impetus to domestic manufacturers, such as Frankenman, and reduced reliance on imports.
India is the fastest-growing country in the regional market. India faces a growing burden of chronic health conditions that significantly drive the demand for surgeries. A 2023 Lancet–ICMR study reported that 11.4% of Indians—about 101 million people—have diabetes, with 15.3% (around 136 million) classified as pre-diabetic. Hypertension affects approximately 35.5% of the adult population, while abdominal obesity impacts 39.5%. According to a study published in Clinical Epidemiology and Global Health, 29.4% of Indians aged 45 and above report diagnosed cardiovascular disease, rising to 38% in those aged 70 and above. These conditions, particularly prevalent among older adults, drive surgical demand across cardiology, endocrinology, and oncology specialties.
The geographical breakdown of the market is as follows:
China (Largest Country)
India (Fastest-Growing Country)
Japan
South Korea
Australia
Rest of APAC
APAC Surgical Staplers Market Share Analysis
The market is moderately fragmented due to the presence of large global players as well as emerging manufacturers. Johnson & Johnson and Medtronic dominate in brand recognition and advanced technologies, but do not control the overall market. The strong government support for local manufacturers, especially in China, boosts the local brands. Moreover, the varied range of products and increasing demand for them in developing countries offer niche players various opportunities to thrive.
Key APAC Surgical Staplers Companies:
Reach Surgical, Inc.
Frankenman International Limited
Grena Ltd.
Purple Surgical
Meril Life Sciences
MediSurge Medical Devices Pvt. Ltd.
Surgsci Medical Ltd.
Changzhou Ankang Medical Instruments Co., Ltd.
Victor Medical Instruments Co., Ltd.
Hopefinder Medical Equipment Co., Ltd.
Jiangsu Ruijin Medical Instruments Co., Ltd.
Genesis MedTech
APAC Surgical Staplers Market Developments
In June 2025, Johnson & Johnson unveiled the ETHICON 4000 Stapler with ETHICON 3D Reloads, patented 3D Stapling Technology, and advanced Gripping Surface Technology.
In March 2025, Surgsci Medical Ltd. received regulatory approval from China's National Medical Product Administration for its Power Endoscopic Cutter Stapler, designed to minimize infection and improve healing.
In January 2025, Genesis Medtech received the Chinese NMPA’s approval for its 90° Articulation Powered Stapler.
In May 2024, Covidien Japan Inc., a subsidiary of Medtronic plc; and HOGY Medical Co. Ltd. collaborated to promote SuReFlnD, a lung lesion making device, equipped with Medtronic’s Endo GIA stapler for precise lung cancer surgeries.
Want a report tailored exactly to your business need?
Leading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Client Testimonials
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Unmatched Standards
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
Complete Data Security
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws